Rapid development of Epstein-Barr virus-associated Hodgkin's disease aftercessation of foscarnet therapy in an HIV-infected patient

Authors
Schramm, C Schlaak, JF Galle, PR
Citation
C. Schramm et al., Rapid development of Epstein-Barr virus-associated Hodgkin's disease aftercessation of foscarnet therapy in an HIV-infected patient, INT J STD A, 11(9), 2000, pp. 609-610
Citations number
6
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
INTERNATIONAL JOURNAL OF STD & AIDS
ISSN journal
09564624 → ACNP
Volume
11
Issue
9
Year of publication
2000
Pages
609 - 610
Database
ISI
SICI code
0956-4624(200009)11:9<609:RDOEVH>2.0.ZU;2-C
Abstract
Epidemiological features suggest a link between Hodgkin's disease (IID) and Epstein-Barr virus (EBV) infection(1). Indeed, EBV genome and expression o f latent antigens can be found in Reed-Sternberg cells(1). In the majority of cases I-ID in HIV patients seems to be EBV-associated(2). We report on a 51-year-old HIV-infected patient in whom EBV-positive HD of mixed cellular ity rapidly developed within one month after cessation of treatment with in travenous foscarnet.